Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management

S Shyam Sunder, UC Sharma… - Signal Transduction and …, 2023 - nature.com
Since their invention in the early 2000s, tyrosine kinase inhibitors (TKIs) have gained
prominence as the most effective pathway-directed anti-cancer agents. TKIs have shown …

Endocrine-related adverse conditions induced by tyrosine kinase inhibitors

S De Leo, M Trevisan, C Moneta, C Colombo - Annales d'Endocrinologie, 2023 - Elsevier
Tyrosine kinase inhibitors (TKIs) have improved outcome for many tumors. Although better
tolerated than cytotoxic chemotherapy, they may cause several adverse events (AEs) and …

The impact of systemic oncological treatments on the fertility of adolescents and young adults—a systematic review

J Himpe, S Lammerant, L Van den Bergh, L Lapeire… - Life, 2023 - mdpi.com
Background: Over the past decades, advancements in oncological treatments have led to
major improvements in survival. Particularly for adolescents and young adults (AYAs) …

Cancer treatment-related ovarian dysfunction in women of childbearing potential: management and fertility preservation options

AC Reynolds, LJ McKenzie - Journal of Clinical Oncology, 2023 - ascopubs.org
PURPOSE To review the complex concerns of oncofertility created through increased
cancer survivorship and the long-term effects of cancer treatment in young adults. DESIGN …

Current issues in fertility preservation among pediatric and adolescent cancer patients

M Nelson, J Levine - Current oncology reports, 2023 - Springer
Abstract Purpose of Review Although fertility preservation is not yet fully integrated into the
comprehensive cancer care of pediatric and adolescent patients, advances continue to take …

[HTML][HTML] Development of protective agents against ovarian injury caused by chemotherapeutic drugs

YN Chi, JM Yang, N Liu, YH Cui, L Ma, XB Lan… - Biomedicine & …, 2022 - Elsevier
Background Chemotherapy is one of the causes of ovarian injury and infertility. Although
assisted reproductive technology helps young female patients with cancer become …

Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial …

GS Mills, V Chadwick, C Tang, J Perram… - The Lancet …, 2023 - thelancet.com
The management of potentially life-threatening malignancies in pregnancy is complicated by
a lack of robust safety and efficacy evidence. This data shortage stems from a historical …

Management of chronic myeloid leukemia and pregnancy: A bibliometric analysis (2000-2020)

Y Wang, L Jiang, B Li, Y Zhao - Frontiers in Oncology, 2022 - frontiersin.org
Background Given the increasing number and survival rates of reproductive-age patients
with chronic myeloid leukemia (CML), several studies aimed to elucidate optimum disease …

Targeted cancer treatment and fertility: effect of immunotherapy and small molecule inhibitors on female reproduction

PL Bussies, EG Richards, SJ Rotz, T Falcone - Reproductive BioMedicine …, 2022 - Elsevier
Targeted cancer therapy is rapidly evolving the landscape of personalized health care.
Novel approaches to selectively impeding tumour growth carry significant potential to …

Germ cell maintenance and sustained testosterone and precursor hormone production in human prepubertal testis organ culture with tissues from boys 7 years+ …

NL Aden, M Bleeke, UR Kordes, B Brunne… - Cells, 2023 - mdpi.com
Human prepubertal testicular tissues are rare, but organ culture conditions to develop a
system for human in vitro-spermatogenesis are an essential option for fertility preservation in …